Tamoxifen treatment inhibited clonogenic potential (~70% inhibition) and anchorage-independent growth of breast cancer cells as expected but co-exposure of cells with leptin abrogated tamoxifen’s growth-inhibitory effects (Fig. 1H–J). Here, LEP is linked to breast carcinoma.